Clinical Trials Logo

Sleep Apnea, Obstructive clinical trials

View clinical trials related to Sleep Apnea, Obstructive.

Filter by:

NCT ID: NCT05289063 Recruiting - Clinical trials for Obstructive Sleep Apnea of Adult

Vascular Endothelial Dysfunction in Sleep Apnea

Start date: October 3, 2022
Phase: Phase 1
Study type: Interventional

This double-blind placebo-controlled parallel group randomized study design will be used to test whether 4 weeks of atorvastatin 10 mg daily reduces levels of inflammatory markers in OSA patients treated with CPAP (standard of care). The purpose of this study is to investigate: 1) whether statins reduce endothelial inflammation and pro-thrombotic conditions in OSA, including in patients adherent to CPAP (Aim 1); and 2) whether statins reduce endothelial inflammation and pro-thrombotic conditions by improving endothelial cholesterol metabolism and trafficking in OSA (Aim 2).

NCT ID: NCT05284045 Completed - Clinical trials for Obstructive Sleep Apnea

Nocebo Effect in OSA Patients With CPAP Treatment

Start date: March 8, 2022
Phase: N/A
Study type: Interventional

This study is aimed to evaluate whether the information provided by health care professionals in the visits previous to start with CPAP treatment may influence the number of reported adverse effects and compliance in patients with obstructive sleep apnea (OSA) in treatment with CPAP.

NCT ID: NCT05276362 Completed - Clinical trials for Obstructive Sleep Apnea

Study Watch Sleep Metric Performance Characterization Study

Start date: March 4, 2022
Phase:
Study type: Observational

This is a multi-center, single-arm, prospective performance evaluation study designed to assess performance of sleep metrics calculated from sensor data that is collected from two versions of the Verily Study Watch as compared to polysomnography.

NCT ID: NCT05272761 Recruiting - OSA Clinical Trials

Impact of Breathing Route on CPAP Effectiveness to Treat Obstructive Sleep Apnea

Start date: January 10, 2021
Phase:
Study type: Observational

To determine the impact of the CPAP route (oronasal vs oral) in patients diagnosed with moderate-severe OSA using CPAP with oronasal mask on CPAP level, residual AHI, and peak flow. In addition, the impact of position (lateral vs supine position) will be evaluated during PSG.

NCT ID: NCT05268471 Not yet recruiting - Clinical trials for Obstructive Sleep Apnea of Adult

Cost-effectiveness Analysis and Conditional Response to the Effect of Positional Devices in Obstructive Sleep Apnea

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The objectives of this study are: - To assess the effectiveness and cost-effectiveness of a vibrating positional device (NightBalance, Philips) in the treatment of positional obstructive sleep apnea compared to conventional CPAP treatment. - To investigate whether a positional device (NightBalance, Philips) avoids supine position after a period of use of the device without actively using the device for a subsequent period of time.

NCT ID: NCT05267808 Recruiting - Clinical trials for Obstructive Sleep Apnea

Pathophysiological Endotyping Using Baseline Polysomnography Data

Start date: February 1, 2022
Phase:
Study type: Observational

The study is designed to develop models to predict site of collapse information using routine polysomnography. In an observational study, the investigators will study 1000 patients with obstructive sleep apnea (OSA) who have had a recent polysomnographic study and will undergo drug-induced sleep endoscopy (DISE) as part of their standard clinical care. Flow shape information from the polysomnographic study will be associated with the DISE results, and a set of prediction models will be developed and validated to detect the site, pattern and degree of upper airway collapse as seen during DISE.

NCT ID: NCT05266131 Completed - Hypertension Clinical Trials

The Effect of Sleep Apnea and Hypertension on Gut Microbiome

Start date: July 1, 2017
Phase:
Study type: Observational

Obstructive sleep apnea (OSA) and hypertension are closely associated diseases. Here we characterized the differences in the gut microbiome which is affected by the two diseases, when the two diseases coexist or are present alone. Fifty-two consecutive patients who underwent polysomnography (PSG) were enrolled and divided into four groups: without OSA or hypertension (OSA0HT0), OSA without hypertension (OSA1HT0), hypertension without OSA (OSA0HT1), and with OSA and hypertension (OSA1HT1). Fecal specimens were collected for 16S rRNA sequencing and the characteristics of community richness, diversity, and composition of the gut microbiome and their relationship with disease were analyzed using bioinformatics methods.

NCT ID: NCT05262439 Recruiting - Clinical trials for Obstructive Sleep Apnea

Post Market Clinical Follow up of ResMed Mask Systems

Start date: May 26, 2022
Phase: N/A
Study type: Interventional

Post Market follow up study to systematically and proactively collect supplementary real world data to confirm the usability and performance of the new generation mask systems. .

NCT ID: NCT05255744 Not yet recruiting - Clinical trials for Obstructive Sleep Apnea

Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol

Start date: March 28, 2024
Phase: N/A
Study type: Interventional

Each Whitsunday mask or AirFit N30i Quiet mask is worn for 7 nights. The overall purpose of this study is to evaluate the performance of the Whitsundays nasal mask system (a prototype mask) compared to the ResMed AirFit N30i Quiet mask system (a benchmark mask) in relation to seal, comfort, usability, overall performance, and efficacy.

NCT ID: NCT05253963 Completed - Clinical trials for Obstructive Sleep Apnea

Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea

Start date: September 29, 2021
Phase: N/A
Study type: Interventional

The effect of CPAP on weight and fluid homeostasis will be assessed. Obstructive sleep apnea treatment-naive subjects will randomized to CPAP and control groups. Weight change, and changes in overnight urinary volume, intra and extracelullar volume, plasmatic B-type natriuretic peptide (BNP) and antidiuretic hormone (ADH) and urinary osmolality will be compared between groups.